bioRxivMicrobiology
Systematic analysis of SARS-CoV-2 infection of an ACE2-negative human airway cell
M. Puray-Chavez, K. M. Lapak, T. P. Schrank, J. L. Elliott, D. P. Bhatt, M. J. Agajanian, R. Jasuja, D. Q. Lawson, K. Davis, P. W. Rothlauf, H. Jo, N. Lee, K. Tenneti, J. E. Eschbach, C. Shema Mugisha, H. R. Vuong, A. L. Bailey, D. N. Hayes, S. P. J. Whelan, A. Horani, S. L. Brody, D. Goldfarb, M. B. Major, S. B. Kutluay
Abstract
Established in vitro models for SARS-CoV-2 infection are limited and include cell lines of non-human origin and those engineered to overexpress ACE2, the cognate host cell receptor. We identified human H522 lung adenocarcinoma cells as naturally permissive to SARS-CoV-2 infection despite complete absence of ACE2. Infection of H522 cells required the SARS-CoV-2 spike protein, though in contrast to ACE2-dependent models, spike alone was not sufficient for H522 infection. Temporally resolved transcriptomic and proteomic profiling revealed alterations in cell cycle and the antiviral host cell response, including MDA5-dependent activation of type-I interferon signaling. Focused chemical screens point to important roles for clathrin-mediated endocytosis and endosomal cathepsins in SARS-CoV-2 infection of H522 cells. These findings imply the utilization of an alternative SARS-CoV-2 host cell receptor which may impact tropism of SARS-CoV-2 and consequently human disease pathogenesis.
- organism: human
- assay: bulk RNA-seq
- assay: proteomics
- research focus: host-pathogen & immune response
- research focus: cell signaling & trafficking
- approach: experimental assay
- approach: statistical model
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- ACE2-independent SARS-CoV-2 infection and mouse adaption emerge after passage in cells expressing human and mouse ACE2
K. Yan, T. Dumenil, … D. J. Rawle·bioRxiv·Dec 16, 2021
- Screening and testing for a suitable untransfected cell line for SARS-CoV-2 studies
Claudia Pommerenke, Ulfert Rand, … Laura Steenpaß·bioRxiv·Jul 9, 2020
- Cell culture model system utilizing engineered A549 cells to express high levels of ACE2 and TMPRSS2 for investigating SARS-CoV-2 infection and antivirals
C.-W. Chang, K. M. Parsi, … R. W. Finberg·bioRxiv·Dec 31, 2021
- Development of an in vitro model for animal species susceptibility to SARS-CoV-2 replication based on expression of ACE2 and TMPRSS2 in avian cells
D. R. Kapczynski, R. Sweeney, … M. Pantin-Jackwood·bioRxiv·Aug 18, 2021
- A basally active cGAS-STING pathway limits SARS-CoV-2 replication in a subset of ACE2 positive airway cell models
M. Puray-Chavez, J. E. Eschbach, … S. B. Kutluay·Nature CommunicationsPeer-reviewed·Sep 27, 2024
- Evaluation of SARS-CoV-2 Entry, Inflammation and New Therapeutics in Human Lung Tissue Cells
J. Grau-Exposito, D. Perea, … M. J. Buzon·bioRxiv·Apr 21, 2021